VIRIDIAN THERAPEUTICS INC (VRDN) Institutional Ownership Changes & 13F Activity
VIRIDIAN THERAPEUTICS INC (VRDN). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Kynam Capital Management, Lp, Paradigm Biocapital Advisors Lp, Price T Rowe Associates Inc, Citadel Advisors Llc, and Deep Track Capital, Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +98,923 | +121.5% | 180,348 | $3.31M | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Sell | -2,276,931 | -98.2% | 41,303 | $758.74K | Q2 2026 | Sep 02, 2026 |
| California State Teachers Retirement System | Buy | +10,381 | +12.8% | 91,402 | $1.68M | Q2 2026 | Aug 24, 2026 |
| Public Employees Retirement System Of Ohio | Buy | +21,070 | — | 21,070 | $387.06K | Q2 2026 | Aug 17, 2026 |
| Kynam Capital Management, Lp | Buy | +4,112,225 | +175.6% | 6,453,877 | $118.56M | Q2 2026 | Aug 14, 2026 |
| Paradigm Biocapital Advisors Lp | Buy | +3,574,895 | +113.5% | 6,723,788 | $123.52M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +2,542,375 | +79.3% | 5,748,410 | $105.60M | Q2 2026 | Aug 14, 2026 |
| Deep Track Capital, Lp | Buy | +2,198,796 | +157.7% | 3,592,740 | $66.00M | Q2 2026 | Aug 14, 2026 |
| Caligan Partners Lp | Buy | +2,193,981 | — | 2,193,981 | $40.30M | Q2 2026 | Aug 14, 2026 |
| Point72 Asset Management, L.P. | Buy | +2,020,372 | +625.8% | 2,343,208 | $43.04M | Q2 2026 | Aug 14, 2026 |
| Fairmount Funds Management Llc | Buy | +1,176,470 | +30.1% | 5,090,928 | $93.52M | Q2 2026 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | Sell | -1,036,098 | -44.7% | 1,279,859 | $23.51M | Q2 2026 | Aug 14, 2026 |
| Avoro Capital Advisors Llc | Buy | +1,000,000 | +66.7% | 2,500,000 | $45.92M | Q2 2026 | Aug 14, 2026 |
| Parkman Healthcare Partners Llc | Buy | +819,640 | +146.9% | 1,377,576 | $25.31M | Q2 2026 | Aug 14, 2026 |
| Schonfeld Strategic Advisors Llc | Buy | +793,508 | — | 793,508 | $14.58M | Q2 2026 | Aug 14, 2026 |
| First Turn Management, Llc | Buy | +758,663 | +83.2% | 1,670,000 | $30.68M | Q2 2026 | Aug 14, 2026 |
| Metlife Investment Management, Llc | Sell | -655,818 | -92.6% | 52,709 | $968.26K | Q2 2026 | Aug 14, 2026 |
| Venrock Adviser, Llc | Sell | -624,792 | -16.1% | 3,257,917 | $59.85M | Q2 2026 | Aug 14, 2026 |
| Perceptive Advisors Llc | Sell | -588,849 | -50.3% | 581,980 | $10.69M | Q2 2026 | Aug 14, 2026 |
| Boothbay Fund Management, Llc | Buy | +541,058 | — | 541,058 | $9.94M | Q2 2026 | Aug 14, 2026 |
| Elmind Capital, Lp | Buy | +450,000 | +84.1% | 984,931 | $18.09M | Q2 2026 | Aug 14, 2026 |
| Ikarian Capital, Llc | Buy | +425,000 | — | 425,000 | $7.81M | Q2 2026 | Aug 14, 2026 |
| Baker Bros. Advisors Lp | Buy | +411,347 | +20.9% | 2,383,025 | $43.78M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Sell | -219,270 | -18.8% | 944,345 | $17.35M | Q2 2026 | Aug 14, 2026 |
| Yiheng Capital Management, L.P. | Buy | +191,729 | +91.9% | 400,464 | $7.36M | Q2 2026 | Aug 14, 2026 |
| Voleon Capital Management Lp | Sell | -172,144 | -63.8% | 97,598 | $1.79M | Q2 2026 | Aug 14, 2026 |
| Novo Holdings A/S | Buy | +135,000 | +6.8% | 2,135,000 | $39.22M | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Buy | +133,046 | +303.0% | 176,955 | $3.25M | Q2 2026 | Aug 14, 2026 |
| Lighthouse Investment Partners, Llc | Buy | +120,000 | — | 120,000 | $2.20M | Q2 2026 | Aug 14, 2026 |
| Eversept Partners, Lp | Buy | +117,873 | +16.5% | 831,142 | $15.27M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about VRDN activity
Which institutional owners are buying VRDN?
Institutional owners buying VRDN include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in VRDN activity?
"Buy" means an investor increased their reported position in VRDN compared to the prior reporting period. This reflects growing exposure to VIRIDIAN THERAPEUTICS INC (VRDN) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in VRDN increasing?
Institutional interest in VRDN can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related VRDN Institutional Insights
- VRDN Overview
- VRDN 13F Institutional Holders
- VRDN Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- VRDN Insider Trading & SEC Form 4 Activity
- VRDN Articles
- Top Institutional Investor Stock Rankings